Clinical Trial Update: Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the combination of low-dose colchicine and ticagrelor to prevent ischemic stroke in patients with stroke due to atherosclerosi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Stroke

Drugs mentioned

• COLCHICINE (Colchicine)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Stroke, Stroke, Ischemic | Phase 3 | Status: RECRUITING